Resume-aware faculty matching

Find professors who actually fit you

Review faculty evidence in public, then use the workspace to turn your background into a shortlist, outreach, and meeting prep.

Profile-awarePaper evidenceSix agents
Seema K. Shah

Seema K. Shah

· Associate Professor of Law (Courtesy)

Northwestern University · Pritzker School of Law

Active 1967–2026

h-index126
Citations70.3k
Papers1.2k505 last 5y
Funding$48.7M1 active

Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.

See your match with Seema K. Shah — sign in to PhdFit.Sign in

About

Seema K. Shah is an Associate Professor of Law (Courtesy) at Northwestern Pritzker School of Law. Her academic focus includes health law, as indicated by her course offerings in this area. She is part of the faculty involved in the Law, Business, and Economics Center and contributes to the academic community through her research and teaching. Her role involves engaging with students and the broader legal community at Northwestern Law, supporting the school's mission to provide comprehensive legal education and research.

Research topics

  • Medicine
  • Internal medicine
  • Cardiology
  • Computer Science
  • Demography
  • Endocrinology
  • Pathology
  • Machine Learning
  • Artificial Intelligence
  • Intensive care medicine

Selected publications

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    New England Journal of Medicine · 2022 · 2546 citations

    BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ejection fraction of 40% or less. Whether SGLT2 inhibitors are effective in patients with a higher left ventricular ejection fraction remains less certain. METHODS: We randomly assigned 6263 patients with heart failure and a left ventricular ejection fraction of more than 40% to receive dapagli…

  • SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

    The Lancet · 2022 · 875 citations

    BACKGROUND: SGLT2 inhibitors are strongly recommended in guidelines to treat patients with heart failure with reduced ejection fraction, but their clinical benefits at higher ejection fractions are less well established. Two large-scale trials, DELIVER and EMPEROR-Preserved, in heart failure with mildly reduced or preserved ejection fraction have been done, providing power to examine therapeutic effects on cardiovascular mortality and in patient subgroups when combined with the earlier trials in…

  • Research Priorities for Heart Failure With Preserved Ejection Fraction

    Circulation · 2020 · 401 citations

    1st authorCorresponding

    Heart failure with preserved ejection fraction (HFpEF), a major public health problem that is rising in prevalence, is associated with high morbidity and mortality and is considered to be the greatest unmet need in cardiovascular medicine today because of a general lack of effective treatments. To address this challenging syndrome, the National Heart, Lung, and Blood Institute convened a working group made up of experts in HFpEF and novel research methodologies to discuss research gaps and to pr…

  • Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

    JAMA · 2020 · 270 citations

    Importance: Patients with heart failure and preserved ejection fraction (HFpEF) are at high risk of mortality, hospitalizations, and reduced functional capacity and quality of life. Objective: To assess the efficacy of the oral soluble guanylate cyclase stimulator vericiguat on the physical limitation score (PLS) of the Kansas City Cardiomyopathy Questionnaire (KCCQ). Design, Setting, and Participants: Phase 2b randomized, double-blind, placebo-controlled, multicenter trial of 789 patients with…

  • Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction

    Circulation · 2020 · 259 citations

    Senior authorCorresponding

    BACKGROUND: A systemic proinflammatory state has been hypothesized to mediate the association between comorbidities and abnormal cardiac structure/function in heart failure with preserved ejection fraction (HFpEF). We conducted a proteomic analysis to investigate this paradigm. METHODS: In 228 patients with HFpEF from the multicenter PROMIS-HFpEF study (Prevalence of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction), 248 unique circulating proteins were quantified by a…

Recent grants

Frequent coauthors

  • Scott D. Solomon

    Harvard University

    567 shared
  • Brian Claggett

    Brigham and Women's Hospital

    421 shared
  • Bertram Pitt

    Northwestern University

    401 shared
  • Carolyn S.P. Lam

    Duke-NUS Medical School

    373 shared
  • Inder S. Anand

    University of Minnesota

    370 shared
  • Nancy K. Sweitzer

    348 shared
  • Marc A. Pfeffer

    Harvard University

    324 shared
  • Amil M. Shah

    319 shared

Labs

  • Northwestern Pritzker School of Law Faculty & ResearchPI

Awards & honors

  • Teaching Awards

Similar researchers at Northwestern University

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Seema K. Shah

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup